Sridevi Challa, MD
Internal Medicine · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Challa’s office at (408) 945-2900 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A137434 · Current
Licensed to practise in California · since 2015 · expires 2027-05-31 · Ntr University of Health Sciences, S.V.S. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Medicaid work
$5,091 in 2022
Medicaid paid $5,091 for 91 billed services this clinician did in 2022, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 59 | $3,628 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 32 | $1,463 |
| 2022 | 91 | 2 | 15 | $5,091 |
| 2021 | 306 | 2 | 21 | $15,806 |
| 2020 | 212 | 2 | 29 | $11,763 |
| 2019 | 208 | 2 | 18 | $9,052 |
| 2018 | 207 | 2 | 22 | $7,229 |
See the largest Medicaid services in earlier years
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 216 | $12,506 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 90 | $3,301 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 184 | $10,472 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 28 | $1,291 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 138 | $6,410 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 70 | $2,643 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 150 | $5,482 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 57 | $1,748 |
Drugs they prescribed that Part D paid
$73,413
Pharmacies billed $73,413 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,499 generic and 185 brand-name prescriptions · $73,413 in drug cost · 37 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 35 | $18,787 | $537 |
| Spiriva Respimat | 12 | $4,785 | $399 |
| Atorvastatin | 279 | $3,307 | $12 |
| Humulin N | 12 | $1,846 | $154 |
| Amlodipine Besylate | 138 | $1,644 | $12 |
See all 34 drugs
| Jardiance | 35 | $18,787 | $537 |
| Spiriva Respimat | 12 | $4,785 | $399 |
| Atorvastatin | 279 | $3,307 | $12 |
| Humulin N | 12 | $1,846 | $154 |
| Amlodipine Besylate | 138 | $1,644 | $12 |
| Levothyroxine | 85 | $1,570 | $18 |
| Alvesco | 12 | $1,394 | $116 |
| Losartan | 93 | $1,138 | $12 |
| Lisinopril | 84 | $1,026 | $12 |
| Albuterol Sulfate Hfa | 53 | $898 | $17 |
| Fluticasone Propionate | 34 | $615 | $18 |
| Atenolol | 48 | $604 | $13 |
| Simvastatin | 45 | $528 | $12 |
| Gabapentin | 27 | $460 | $17 |
| Tamsulosin | 27 | $430 | $16 |
| Hydrochlorothiazide | 35 | $403 | $12 |
| Glipizide Er | 14 | $386 | $28 |
| Alendronate | 39 | $376 | $10 |
| Metformin | 35 | $343 | $10 |
| Veo Insulin | 16 | $339 | $21 |
| Lisinopril-Hydrochlorothiazide | 22 | $300 | $14 |
| Metoprolol | 26 | $296 | $11 |
| Metformin Hcl Er | 26 | $255 | $10 |
| Pantoprazole | 22 | $232 | $11 |
| Glipizide | 20 | $211 | $11 |
| Trazodone | 16 | $209 | $13 |
| Famotidine | 18 | $186 | $10 |
| Hydrocortisone | 14 | $183 | $13 |
| Allopurinol | 15 | $178 | $12 |
| Fluoxetine | 14 | $160 | $11 |
| Metoprolol | 12 | $146 | $12 |
| Lovastatin | 11 | $128 | $12 |
| Omeprazole | 13 | $107 | $8 |
| Hydralazine | 11 | $96 | $9 |
Year by year
| 2024 | 1,702 | 291 | None | 11% | $73,413 |
| 2023 | 1,219 | 263 | None | 13% | $53,557 |
| 2022 | 141 | 65 | None | 13% | $4,431 |
| 2021 | 280 | 117 | 4% (11) | None | $8,383 |
| 2020 | 194 | 96 | 7% (14) | 9% | $6,535 |
| 2019 | 266 | 130 | 8% (22) | None | $7,793 |
| 2018 | 260 | 120 | 7% (19) | 13% | $10,344 |
| 2017 | 222 | 100 | 6% (14) | 16% | $10,214 |
| 2016 | 325 | 129 | 5% (17) | None | $10,480 |
| 2015 | 116 | 55 | None | None | $4,780 |
| 2014 | 31 | 14 | 0% (0) | None | $1,029 |
| 2013 | 28 | None | 0% (0) | None | $844 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Jardiance | 22 | $17,188 | $781 |
| Spiriva Respimat | 11 | $3,199 | $291 |
| Atorvastatin | 159 | $1,948 | $12 |
| Amlodipine Besylate | 94 | $1,048 | $11 |
| Levothyroxine | 41 | $867 | $21 |
| Losartan | 68 | $820 | $12 |
| Lisinopril | 68 | $764 | $11 |
| Albuterol Sulfate Hfa | 44 | $746 | $17 |
| Tamsulosin | 28 | $385 | $14 |
| Atenolol | 32 | $379 | $12 |
| Gabapentin | 19 | $327 | $17 |
| Fluticasone Propionate | 24 | $319 | $13 |
| Metoprolol | 32 | $314 | $10 |
| Alendronate | 30 | $303 | $10 |
| Simvastatin | 26 | $286 | $11 |
| Metformin | 24 | $248 | $10 |
| Metformin Hcl Er | 26 | $214 | $8 |
| Lisinopril-Hydrochlorothiazide | 18 | $208 | $12 |
| Hydrochlorothiazide | 19 | $194 | $10 |
| Pantoprazole | 20 | $161 | $8 |
| Glipizide | 13 | $142 | $11 |
| Omeprazole | 12 | $130 | $11 |
| Nitrofurantoin Mono-Macro | 12 | $124 | $10 |
| Famotidine | 16 | $119 | $7 |
| Hydralazine | 11 | $83 | $8 |
2022: 1 drug
| Atorvastatin | 20 | $218 | $11 |
2021: 6 drugs
| Pantoprazole | 17 | $185 | $11 |
| Atorvastatin | 17 | $107 | $6 |
| Doxycycline Hyclate | 11 | $100 | $9 |
| Metoprolol | 20 | $73 | $4 |
| Prednisone | 15 | $56 | $4 |
| Furosemide | 16 | $48 | $3 |
2020: 2 drugs
| Cefdinir | 19 | $239 | $13 |
| Pantoprazole | 14 | $100 | $7 |
2019: 4 drugs
| Cefdinir | 15 | $315 | $21 |
| Oxycodone-Acetaminophen | 12 | $81 | $7 |
| Prednisone | 18 | $63 | $3 |
| Amlodipine Besylate | 14 | $37 | $3 |
2018: 8 drugs
| Cefdinir | 20 | $433 | $22 |
| Amiodarone | 11 | $189 | $17 |
| Atorvastatin | 11 | $84 | $8 |
| Metoprolol | 15 | $65 | $4 |
| Prednisone | 15 | $64 | $4 |
| Oxycodone-Acetaminophen | 12 | $52 | $4 |
| Amlodipine Besylate | 11 | $35 | $3 |
| Furosemide | 11 | $32 | $3 |
2017: 3 drugs
| Metoprolol | 15 | $48 | $3 |
| Prednisone | 15 | $43 | $3 |
| Furosemide | 14 | $34 | $2 |
2016: 8 drugs
| Clopidogrel | 22 | $279 | $13 |
| Atorvastatin | 20 | $210 | $11 |
| Cefdinir | 11 | $197 | $18 |
| Metoprolol | 27 | $99 | $4 |
| Oxycodone-Acetaminophen | 13 | $87 | $7 |
| Lisinopril | 12 | $52 | $4 |
| Prednisone | 14 | $47 | $3 |
| Furosemide | 12 | $36 | $3 |
Professional record
- NPI
- 1285981803
- Licence
- AZ 50768, CA A137434California A137434: Current · expires 2027-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Hospitalist (208M00000X)
- Mailing address
- 770 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2012-08-14
- NPI last updated
- 2022-07-11
- NPI record certified
- 2022-07-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6644 E Baywood Ave, Mesa, AZ, 85206
This office lists an electronic records connection.